REQUEST A DEMO
Total
USD $0.00
Search more companies

Carewin Pharmaceuticals (Gujarat) Private Limited (India)

Main Activities: Sales Financing
Full name: Carewin Pharmaceuticals (Gujarat) Private Limited Profile Updated: February 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Carewin Pharmaceuticals (gujarat) Private Limited is an unlisted company, incorporated on 17/07/1995. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U65910GJ1995PTC026756 and registration number is 026756. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
38, Saket Industrial Estate-2 Sarkhej-Bavla Highway, Post Moraiya, Sanand
Ahmedabad; Gujarat; Postal Code: 382210

Contact Details: Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.
Registered Capital:
Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.
Financial Auditors:
Purchase the Carewin Pharmaceuticals (Gujarat) Private Limited report to view the information.
Incorporation Date:
July 17, 1995
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Carewin Pharmaceuticals (Gujarat) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.67%
Total operating revenue
9.8%
Operating profit (EBIT)
-18.1%
EBITDA
-13.84%
Net Profit (Loss) for the Period
-18.01%
Total assets
22.93%
Total equity
19.49%
Operating Profit Margin (ROS)
-1.13%
Net Profit Margin
-0.84%
Return on Equity (ROE)
-7.46%
Debt to Equity Ratio
-16.69%
Quick Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?